band of approximately 16 kDa with Sprouty-1 antibody derived from proteolytic fragmentation of Sprouty-1. In embryonic day (E) 14 and E16 lungs, Sprouty-1 and Sprouty-2 were expressed both in epithelial and peripheral mesenchymal cells. In adult rat lung, bronchiolar and alveolar type II epithelial cells showed staining for both Sprouty-1 and Sprouty-2. Sprouty-1 expression was also seen in alveolar type I epithelial cells. Conclusion: In light of the proximity of the distribution of Sprouty to that of FGF-10 (peripheral mesenchyme) and its receptor FGFR2IIIb (distal tubular epithelium) in lung development, and the finding that FGF-9, which is expressed in mesothelial cells, upregulates FGF-10, it appears that Sprouty expression in epithelial and mesenchymal cells during branching morphogenesis is closely related to signaling by FGF-9 and FGF-10.
growth factors and other signaling molecules [1, 2] . Of the latter, Sprouty acts as a common antagonist of a number of growth factors and participates in organogenesis [3] [4] [5] [6] [7] . Sprouty was first discovered during genetic studies on Drosophila [4] and shown to regulate tracheal branching and eye development in Drosophila [3] [4] [5] 7] . At least 4 Sprouty homologs (Sprouty-1, -2, -3 and -4) have been identified in vertebrates, and all share a C-terminal cysteine-rich domain [8, 9] . The question of whether Sprouty, similar to its function in Drosophila tracheal branching, also regulates lung branching in vertebrates has been addressed [6, 10] . Inhibition of Sprouty-2 expression with antisense oligonucleotides in cultured mouse lung explants enhanced branching [6, 10] , indicating that Sprouty-2 acts as an inhibitor of lung branching morphogenesis.
Several studies have demonstrated that Sprouty-1 and Sprouty-2 mRNAs are expressed at various stages of lung development and in adults [6, [9] [10] [11] [12] . This report compares the distribution of Sprouty-1 and Sprouty-2 proteins by immunohistochemistry in developing and adult rat lung. Our results indicate that Sprouty-1 and Sprouty-2 have both distinct and overlapping patterns of expression in developing lung, beginning with the onset of branching through to the adult stage. This report is the first to show that Sprouty-1 and -2 proteins are expressed by adult alveolar epithelial type II cells. Furthermore, Western blot analysis of bronchoalveolar lavage fluid (BAL) from adult rat lungs using Sprouty-1 antibody revealed the presence of a 16-kDa polypeptide in BAL, possibly released after proteolysis of the nascent protein.
Materials and Methods

Animals
Timed pregnant rats of the Sprague-Dawley strain were obtained from Hilltop (Scottsdale, Pa., USA) and housed in pathogen-free conditions in accordance with institutional guidelines.
PCR Cloning of Rat Sprouty Homologs
Rat Sprouty-1 and Sprouty-2 cDNAs were obtained by RT-PCR using RNA obtained from adult rat lungs and PCR primers derived from published mouse cDNA sequences [9] . The products were amplified using AmpliTaq DNA polymerase (Perkin Elmer Cetus). After initial denaturation at 95 ° C for 5 min, the samples were amplified for 40 cycles, each consisting of annealing at 55 ° C for 1 min, elongation at 72 ° C for 3 min and denaturation at 95 ° C for 40 s. The final elongation was for 15 min at 72 ° C. The amplified DNA was cloned into the TA vector (Invitrogen) and sequenced on an ABI Prism 377 sequencer at the University of Pittsburgh, School of Medicine Research Support Facilities.
Antibodies
Rat Sprouty-1 and Sprouty-2 amino acid sequences were deduced from the nucleotide sequences and used to select peptides for raising polyclonal antibodies. Sprouty-1 and Sprouty-2 antibodies were prepared by Bethyl Laboratories (Montgomery, Tex., USA) by immunizing rabbits with the KLH-conjugated peptides (rat Sprouty-1 peptide: AVEGRQRLDYDRDT; rat Sprouty-2 peptide: QPPRLQPSQVHSSRA). The peptides for immunization were selected from the more divergent N-terminal amino acid sequences of Sprouty-1 and Sprouty-2 (the homology at the N-terminal sequence was 43%, compared with 68% at the cysteine-rich C-terminal sequence). The antibodies were affinity purified on bound-peptide columns prior to use in Western blot analysis and immunocytochemistry. A caveolin-1 antibody was obtained from Dako (Carpinteria, Calif., USA).
Fractionation of Rat Lung Homogenate
Adult rat lungs were homogenized in 0.25 M sucrose containing protease inhibitor cocktail (Roche, Indianapolis, Ind., USA) and centrifuged at 6,500 rpm (5,000 g ) in a Beckman JA20 rotor/ J2-21 centrifuge (Beckman Instruments, Palo Alto, Calif., USA) to obtain a pellet (6.5 K pellet). The supernatant was then centrifuged at 13,000 rpm (20,000 g ) to obtain supernatant (13 K supernatant) and pellet (13 K pellet) fractions. BAL was collected by intratracheal instillation of normal saline into lungs of adult rats that were given lethal doses of Nembutal. Cell debris was removed from BAL by centrifugation, and the clear supernatant was concentrated by ultrafiltration.
Western Blot
The 6.5 and 13 K pellets, 13 K supernatant and BAL were subjected to Western blot analysis using Sprouty-1 or Sprouty-2 antibody. Samples were electrophoresed on 10% acrylamide gels (Novex, San Diego, Calif., USA), and Western blot analysis was carried out using a commercial kit (Western Breeze, Novex).
Type II Cell Isolation and Northern Blot
Alveolar epithelial type II cells were isolated from adult rats, and Northern blot analysis was performed according to our previously described protocols [13] [14] [15] . Briefly, total RNA extracted from adult rat lung and isolated type II cells were fractionated in 1% agarose gels containing 0.66 M formaldehyde. Gels with ethidium bromide-stained bands were photographed under UV light and treated with 0.05 N NaOH prior to transfer to GeneScreen Plus (NEN Research Products, Boston, Mass., USA) with a Transvac Blotting System (Hoefer Scientific, San Francisco, Calif., USA). Blots were exposed to UV light in a UV Stratalinker (Stra tagene, San Diego, Calif., USA). Northern blot was sequentially hybridized with 32 P-labeled cDNA probes for Sprouty-1 and Sprouty-2.
Immunohistochemisry
Lung tissue was fixed in 4% paraformaldehyde, embedded in OCT compound and frozen at -80 ° C. Frozen sections were stained with antibody using the EnVision System (Dako) and counterstained with hematoxylin.
In situ Hybridization
The procedure using non-RI probes is detailed in our earlier publication [11] . Alkaline phosphatase and peroxidase substrates were Fast Red and diaminobenzidine, respectively.
Results
Sprouty-1 and Sprouty-2 Proteins Have both Distinct and Overlapping Distribution Patterns in Lung Subcellular Fractions
Three major fractions (6.5 K pellet, 13 K pellet and 13 K supernatant) and BAL were examined by Western blot analysis using antibodies to caveolin-1 and Sprouty-1 ( fig. 1 ) and Sprouty-2 ( fig. 2 ). Caveolin-1 was included in the study because of its close intracellular association with Sproutys [16] . The 6.5 and 13 K pellets and 13 K supernatant all showed the presence of caveolin-1, but the highest amount was found in the 13 K pellet fraction ( fig. 1 A) . A band of about 30 kDa was detected in the 13 K supernatant fraction with the Sprouty-1 antibody. The band was not detected in the 6.5 and 13 K pellet fractions or in BAL. However, an immunoreactive band of approximately 16 kDa was detected in BAL ( fig. 1 B) . A 34-kDa band was detected in the 13 K pellet fraction using Sprouty-2 antibody ( fig. 2 A) . No immunoreactive band was seen in the Peptide-absorbed Sprouty-1 antibody 6 . 5 K p e l l e t B A L 6 . 5 K p e l l e t 1 3 K p e l l e t 1 3 K s u p e r n a t a n t B A L 6 . 5 K p e l l e t 1 3 K p e l l e t 1 3 K s u p e r n a t a n t 1 3 K p e l l e t 1 3 K s u p e r n a t a n t
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Sprouty-2 antibody 6 . 5 K p e l l e t B A L B A L 1 3 K p e l l e t B A L 1 3 K p e l l e t B A L 1 3 K p e l l e t B A L 1 3 K p e l l e t 1 3 K p e l l e t 1 3 K s u p e r n a t a n t 37 kDa DTT 37 kDa 6.5 K pellet and 13 K supernatant fractions or in BAL using Sprouty-2 antibody ( fig. 2 A) . These immunoreactive bands were not seen when the antibodies were preabsorbed with the Sprouty peptides ( fig. 1 C, 2 C) .
Sprouty-1 and Sprouty-2 mRNA Expression in Isolated Type II Cells
To determine if Sproutys are actually expressed in rat lung, we investigated the expression of Sprouty-1 and Sprouty-2 mRNA in adult rat lung and isolated alveolar epithelial type II cells, which are one of the major components in lung epithelial cells ( fig. 3 ). High expression of mRNA of both Sproutys was seen in the lung and type II cells. The latter appear to be the major cell type expressing Sproutys in adult rat lung.
Localization of Sprouty-1 and -2 in Embryonic Rat Lung
The distribution of Sprouty-1 and Sprouty-2 in embryonic day (E) 14, E16, E18 and adult rat lungs was determined by immunohistochemistry. In E14 lung, Sprouty-1 staining was seen throughout the airway epithelium, more predominantly at the basolateral surfaces of epithelial cells ( fig. 4 , arrows in B, D) . Some of the mesenchymal cells adjacent to the epithelium and at the periphery were also stained ( fig. 4 , arrows in C, arrowheads in B, D). Sprouty-2 staining was seen in airway epithelium, more predominantly at the lumenal surfaces ( fig. 5 , arrows in C, D). Additionally, mesenchymal cells at the periphery were stained ( fig. 5 , arrowheads in B, D). In E16 lung, intense staining for both Sproutys was seen in the distal airway epithelium and adjoining peripheral mesenchymal cells ( fig. 6 ). Uniform Sprouty-1 staining was seen at E16 in the distal airway epithelium ( fig. 6 , arrows in E), whereas Sprouty-2-stained cells were present at the leading edges of the distal epithelium ( fig. 6 , arrow in F) . Sprouty-1 and Sprouty-2 staining was also detected in some of the epithelial cells of the proximal tubules ( fig. 6 , short arrows in C, D) . In E18 lung, strong staining for Sprouty-1 and Sprouty-2 was restricted to the distal airway epithelium ( fig. 7 ) . The proximal airway epithelium was weakly stained for both proteins ( fig. 7 A, B) . No staining was detected in peripheral mesenchyme adjoining the distal alveolar tip at this stage ( fig. 7 B-D) .
Comparison of mRNA Expression of Sprouty-1, Sprouty-2 and Surfactant Protein C by Dual-Probe in situ Hybridization in E18 Lungs
To compare the cellular expression pattern of Sprouty-1, Sprouty-2 and surfactant protein (SP-C), which is usually expressed by type II cells, mRNA, we determined the expression of combinations of these mRNAs by dual-probe in situ hybridization in E18 lungs ( fig. 8 ) . Coexpression of Sprouty-1 or Sprouty-2 and SP-C mRNA was observed in epithelial cells of the distal alveolar buds ( fig. 8 , arrows in A, B) . In addition, coexpression of Sprouty-1 and Sprouty-2 mRNA was observed in epithelial cells of the distal alveolar buds ( fig. 8 , arrows in C, D) . Sprouty-1 mRNA was also expressed in the surrounding mesenchymal cells of the bronchioles ( fig. 8 , arrowheads in A, C). From these findings, the overall distribution of Sprouty-1 and Sprouty-2 mRNA is overlapping in distal alveolar buds expressing SP-C mRNA and distinct in peribronchiolar mesencymal cells with regard to Sprouty-1 mRNA expression.
Localization of Sprouty-1 and Sprouty-2 in Adult Rat
Lung Expression of Sprouty-1 and Sprouty-2 was examined by immunohistochemistry in adult rat lungs and is shown in figures 9 and 10 , respectively. Sprouty-1 expression was strong in the bronchiolar epithelium ( fig. 9 B, C) . In the alveolar region, epithelial type I and type II cells were frequently stained ( fig. 9 D) . Intense staining for Sprouty-2 was also seen in the bronchiolar epithelial cells ( fig. 10 B,  C) . In these cells, staining was often seen in membranes surrounding cytoplasmic vacuoles/vesicles ( fig. 10 , arrows in C, inset). Sprouty-2 expression was also seen in alveolar epithelial type II cells ( fig. 10 , arrows in D). No staining was detected when Sprouty-1 and Sprouty-2 peptide-absorbed antibodies were used for staining ( fig. 9 A, 10 A) . Overall, Sprouty-1 and Sprouty-2 protein distribution was similar to our previously reported mRNA expression [11] .
Distribution of Sprouty-1 and Sprouty-2 mRNA Determined by in situ Hybridization
To verify the cellular expression of Sprouty-1 and Sprouty-2 by immunohistochemistry, we performed in situ hybridization to identify the cellular distribution of mRNA expression of both Sproutys in E18 lungs by comparing their expression with Clara cell 10-kDa protein (CC10), which is usually expressed and secreted by Clara cells, and SP-C mRNA expression ( fig. 11 ). Sprouty-1 and, to a lesser extent, Sprouty-2 mRNAs were expressed in the bronchiolar epithelial cells ( fig. 11 , arrows in C, D) . In the alveolar region, mRNA expression of both Sproutys was seen in type II cells, which were cuboidal and usually located at the corner of the alveoli ( fig. 11 , arrows in E, F). In ad dition, expression of Sprouty-1 mRNA was also seen in type I cells, which were flattened and usually located between the corners of the alveoli ( fig. 11 , arrowheads in E). Overall, these results were similar to the Sprouty-1 and Sprouty-2 protein distribution and to our previous findings for mRNA expression in the developing and adult rat lung [11] . 
Discussion
Sprouty has been shown to inhibit signaling by several tyrosine kinase receptors [3] [4] [5] 7] . In Drosophila, Sprouty acts as an antagonist of fibroblast growth factor (FGF) signaling and its expression is induced by the same signaling pathway that it inhibits [4] . Drosophila Sprouty is known to regulate tracheal branching by limiting the action of Branchless, an FGF that acts as an inducer of branching [4] . The present study demonstrates that Sprouty-1 and Sprouty-2 proteins are expressed in early embryonic lung both in the epithelial cells of distal tubules and in peripheral mesenchymal cells. Peripheral mesenchymal cells are also known to express FGF-10, which induces airway branching by its action as a chemoattractant on advancing tubular epithelium [6, 11, 17, 18] . FGF-10 is required for lung development; FGF-10 knockout animals lack lungs [19, 20] . It is not known whether Sprouty expression in distal epithelial and mesenchymal cells is in response to FGF-10 or whether other growth factor(s) released in the vicinity induce their expression. A potential candidate is FGF-9, which is expressed by mesothelial cells and also by distal epithelium from the midpseudoglandular stage in embryonic mouse lung and up-regulates Fgf-10 expression in the mesenchyme [21] . In addition, it was also recently reported that FGF-9 signaling stimulates Spred and Sprouty expression in embryonic mouse pancreas mesenchyme [22] . These findings indicate that FGF-9 may also regulate Sprouty expression in neighboring mesenchymal and epithelial cells in embryonic rat lung development. Overall, our results point to close proximity of Sprouty-1 and Sprouty-2 expression to the expression domains of FGF, similar to the findings reported by another group in the development of many organs [9] . In E14 and E16 lungs, Sprouty-1 and Sprouty-2 were expressed in epithelial and mesenchymal cells, whereas in E18 lungs at the completion of branching morphogenesis, the expression of these proteins was not detected in peripheral mesenchymal cells and was restricted to epithelial cells. These findings suggest that normal branching morphogenesis may require mesenchymal Sprouty expression.
In adult rat lung, Sprouty-1 and Sprouty-2 mRNAs and proteins are present in alveolar epithelial type II cells. While current evidence suggests that Sprouty-2 is a key regulator of branching morphogenesis [10] , its function as well as that of other Sprouty homologs during branching morphogenesis and later stages of lung development and in the adult rat lung remain to be investigated. There is some evidence suggesting that Sprouty may play a role in cell differentiation contrary to its established role as a general inhibitor of receptor tyrosine kinase signaling. Wong et al. [23] demonstrated that both Sprouty-1 and Sprouty-2 abrogate epidermal growth factor receptor ubiquitylation and endocytosis, enhance epidermal growth factor-induced ERK signaling and induce differentiation of PC12 cells. It has also been reported that Sprouty-2 regulates oncogenic K-ras in lung development and in the context of K-ras G12D -mediated lung tumorigenesis by limiting tumor number and overall tumor burden [24] .
The presence of a 16-kDa polypeptide in BAL is a new and potentially important finding. The polypeptide may have resulted from proteolytic processing of nascent Sprouty-1 (30 kDa). There are two potential proteolytic cleavage sites consisting of RXXR sequences. These sequences are present in Sprouty-1 protein at amino acids 143-146 and 146-149. Cleavage at these sites would yield a fragment of approximately 16 kDa, recognizable by Western blot analysis using the antibody to a Sprouty-1 peptide (amino acids 20-33). It is not yet clear whether the protein processing occurs intracellularly with the secretion of the fragment or extracellularly after secretion by the cell. Whether Sprouty proteins are actively secreted is controversial. The initial studies on Drosophila Sprouty suggested it has a cell nonautonomous action as an extracellular antagonist of FGF signaling [4, 5] . Sprouty protein was found to be localized in a punctate pattern resembling intracellular endocytic uptake vesicles or secretory vesicles in developing eye discs [5] . In contrast, there is evidence that Sprouty homologs are intracellular antagonists of receptor tyrosine kinase pathways and are localized at the inner surface of the plasma membrane [3, 16, 25] . Future studies would determine the nature and site of Sprouty-1 protein processing in the lung and the function, if any, of the 16-kDa Sprouty-1 fragment.
